Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Tennant Biomodulator® PRO Device Designed by AVAZZIA Effects on Perfusion

NCT03843307 is registered in ClinicalTrials.gov with Avazzia, Inc as lead sponsor.

NCT NCT03843307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03843307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Tennant Biomodulator® PRO Device Designed by AVAZZIA Effects on Perfusion
Lead sponsor
Avazzia, Inc
Phase
Not applicable
Overall status
Terminated
Start date
April 24, 2019
Completion date
April 12, 2021
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

perfusion; complications, wound; foot